Frédéric Millot

8PUBLICATIONS
71CO-AUTHORS
Adolescent healthAutoimmunityMedical infection agents (incl. prions)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
Characteristics and Outcomes of Adolescents (15-18 Years) with Chronic Myelogenous Leukemia (CML) in Chronic Phase: The Experience of the International Registry of Childhood CML.

|Oct 21, 2025
Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiency.

Marion Blachez, Nathalie Aladjidi, Thomas Modot

|Oct 15, 2025
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: a propensity score-matched study.

Thomas Pincez, Helder Fernandes, Guy Leverger

|Mar 05, 2025
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations.

Frédéric Millot, Mirella Ampatzidou, Nirmalya Roy Moulik

|May 24, 2024
Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy.

Charles Bobin, Yasmine Iddir, Charlotte Butterworth

|Oct 09, 2020
Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry.

Adalet Meral Günes, Frédéric Millot, Krzysztof Kalwak

Pageof 2

Frequent Collaborators

3 joint publications

Krzysztof Kalwak

3 joint publications

Barbara De Moerloose

3 joint publications

Meinolf Suttorp

2 joint publications

Isabelle Pellier